Benefits:
- Supports the respiratory system.
- Encourages proper nasal function.
- Helps maintain nasal tissues.
- Is ephedra-free.
- Formerly called Sinus Support EF
How It Works:
Provides nutritional support of respiratory cleansing and tissue-protecting processes. The herbs in Sinus Support EF provide practical and safe support for the respiratory system, especially when pollen levels soar. Sinus Support EF supports nasal passages and supplies nutrients for proper respiratory function. Sinus Support EF features synephrine (from immature orange peel), which possesses properties somewhat similar to the alkaloid ephedrine in providing respiratory support, but it acts much more mildly in the body.
Ingredients:
Capsicum fruit, burdock root, goldenseal root, parsley herb, horehound herb, althea root, bitter orange fruit and yerba santa herb.
Recommended Use:
Take 2 capsules with a meal three times daily.
Sinus Support features an exclusive blend of herbs with a long history of traditional use for powerful, natural respiratory support. Burdock’s use has spanned ages and continents, as traditional practitioners in China, India, Europe and North America have prescribed it for respiratory support. Its dried roots were also used as a food source throughout the winter.
Native Americans traditionally used goldenseal to support healthy mucous membranes of the respiratory, digestive and urinary tracts. Eclectic physicians (doctors who recommended herbal remedies) of the early 20th century considered it a critical herb for stomach and intestinal issues.
Marshmallow’s history as a health supplement began in the 9th century, but it didn’t become the more commonly known treat until French confectioners made Pâté de guimauve roughly 1,000 years later. While the Greeks used marshmallow to dress wounds and soothe throats, Roman, Egyptian and Arab practitioners expanded its use for a variety of health needs.
Revered by Native American tribes for its respiratory support, yerba santa was traditionally brewed into a tea, eaten or used as a poultice. It was first listed in the Eclectic Medical Journal in 1875, and it was added to the Pharmacopoeia of the United States in 1894.